HeartSciences (HSCS) Operating Leases (2022 - 2026)
HeartSciences (HSCS) posted quarterly Operating Leases of $175501.0 for Q2 2026, down 44.2% year-on-year from $314527.0 in Q2 2025, and down 44.2% on a QoQ basis from $314527.0 in Q4 2025.
HeartSciences (HSCS) Operating Leases (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Operating Leases for 5 consecutive years, with $175501.0 the latest figure, recorded in Q2 2026.
- Quarterly Operating Leases fell 44.2% year-over-year to $175501.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $175501.0 (down 44.2% YoY) and the FY2026 annual result came in at $175501.0, down 44.2% from the prior year.
- Operating Leases retreated to $175501.0 in Q2 2026 per HSCS's latest filing, from $314527.0 in the prior quarter.
- Over the last five years, Operating Leases for HSCS reached as high as $583016.0 in Q1 2023 and fell as low as $175501.0 in Q2 2026.
- A 5-year average of $401581.9 and a median of $405743.0 in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases declined 11.35% — and 2026, when it slumped 44.2%.
- Year by year, Operating Leases stood at $549227.0 in 2022, then declined by 11.35% to $486885.0 in 2023, then fell by 22.72% to $376241.0 in 2024, then dropped by 16.4% to $314527.0 in 2025, then sank by 44.2% to $175501.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $175501.0, $314527.0, and $247263.0 for Q2 2026, Q4 2025, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | HeartSciences | 6.62 Mn | 4.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 175,501.00 |
| Dec 31, 2025 | 314,527.00 |
| Oct 31, 2025 | 247,263.00 |
| Jul 31, 2025 | 281,570.00 |
| Apr 30, 2025 | 314,527.00 |
| Jan 31, 2025 | 345,844.00 |
| Oct 31, 2024 | 376,241.00 |
| Jul 31, 2024 | 405,743.00 |
| Apr 30, 2024 | 434,045.00 |
| Jan 31, 2024 | 460,859.00 |
| Oct 31, 2023 | 486,885.00 |
| Jul 31, 2023 | 512,145.00 |
| Apr 30, 2023 | 536,335.00 |
| Jan 31, 2023 | 583,016.00 |
| Oct 31, 2022 | 549,227.00 |